Magic Mushrooms. LSD. Ketamine. The Drugs That Power Silicon Valley.
The world's masters often utilize ketamine, LSD, hallucinogenic mushrooms, and other psychoactive drugs. This is the outcome of a thorough inquiry by the Wall Street Journal, not the crazy concept of some internet nutcase.
The psychological profiles of some of the richest individuals in the world, many of whom work in the field of new technologies, are thus presented to us by the American newspaper in a somewhat unsettling manner.
The temple of so-called global invention, Silicon Valley, would be where the unethical use of these medications would take place. the region of southern California that is home to the majority of multinational corporations and technology-focused start-ups. And in fact, Elon Musk, the creator of Tesla, and Sergey Brin, the creator of Google, are the first names to be mentioned as a result of the Wall Street Journal inquiry.
The first is depicted as a regular consumer of hallucinogenic mushrooms, which are psychoactive drugs that change perceptions of reality by causing the perception of things that are actually absent. The rationale for this widespread usage of psychotropic drugs was described by Karl Goldfield, a former consultant to numerous Silicon Valley corporations. The concept of microdosing was then outlined by Goldfield: these medications are used in very small amounts, and the only way to determine where the line between so-called therapeutic usage and addiction may be drawn is by personal experience.
While the Wall Street Journal research mentions a chronic usage that is done without medical support and especially during working hours, there is actually still much to learn about the use of substances like ketamine and LSD for therapeutic purposes. of labor. Elon Musk, on the other hand, would reportedly take ketamine, a psychoactive drug that is used as an anesthetic in medicine, according to the testimonials gathered by the American publication.
Elon Musk wrote a tweet shortly after the WSJ piece went live that does not dispute this evidence but instead emphasizes how ketamine can be a more effective treatment for depression than many medications. The tweet appears to have been removed as of right now. Then there is the testimony of Spencer Shulem, the CEO of an artificial intelligence start-up, who admits to regularly taking LSD microdoses before gradually increasing the dosage every three months.
The widespread usage of these psychoactive drugs would have encouraged users to host psychedelic gatherings. Thus, parties based on the widest range of drugs take the place of the after-work aperitif. The Wall Street Journal reports that these gatherings are managed by the Signal messaging software, which ensures user anonymity. Participants are frequently forced to sign a confidentiality agreement in addition to paying an entry ticket fee of several hundred dollars, according to the Wall Street Journal.
The prevalence of psychotropic drug usage among persons engaged in the most cutting-edge artificial intelligence initiatives does not appear to be a coincidence. These people appear to have the view that since humans are flawed, they are no longer adequate to handle the issues of the future. Therefore, psychotropic drugs or machines must be used to directly replace our body.